For the remaining 29 cancers, notable differential expression of KANK2 was observed in the molecular subtypes of BRCA, COAD, GBM, KIRP, HNSC, LUSC, LGG, PCPG, STAD, and OV (Figure 4 A-J), as well as in immune subtypes of BLCA, BRCA, ESCA, CESC, LIHC, LUAD, LUSC, MESO, OV, PCPG, PRAD, STAD, and UCEC (Figure 4 K-T). The gene discussed is KANK2; the disease is cancer.